Our Medicines

Help Shape Patient Care

 

 

Below is a list of the medicines Lilly currently markets in Canada, the Product Monographs (a scientific document that describes the medication’s properties, claims, indications, conditions of use and safety information) and Consumer Information/Patient Medication Information (Part 3 of the Product Monograph). User Manuals/Instructions for Use for our devices are also available for download on this page.

Please note that Canadian laws and regulations limit the amount of information on our products that we can provide to the general public via our web site and/or by other means. We encourage consumers who have questions about our products to speak to their health care professional or to contact the Lilly Customer Response Centre at 1-888-545-5972.

Lilly is committed to patient safety. Our goal is to ensure that the benefits and risks of our medications are continuously monitored and well-understood by Lilly, regulators, health care providers and patients. Click here to find out more about our commitment to patient safety.

For information related to drug shortages: please click here to access Drug Shortages Canada for current information on drug shortages in Canada.

The product information on this web site is intended for residents of Canada only.

Product Product Monograph Patient Medication Information / Consumer Information User Manual / Instructions for Use Additional Information
Adcirca® (tadalafil) Adcirca Product Monograph    
Alimta® (pemetrexed)    
Axiron® (testosterone & topical solution, 2%)    
BasaglarTM (insulin glargine) BasaglarTM KwikPen®  
Cialis® (tadalafil)   Health Care Professional Letter (June 2006)

Public Communication (June 2006)
Cymbalta® (duloxetine hydrochloride)   Health Care Professional Letter (January 2008)
CyramzaTM (ramucirumab)    
Effient® (prasugrel hydrochloride)   Health Care Professional Letter  (January 2014)

Public Communication (January 2014)
EntuzityTM KwikPen® (insulin injection 500 units/mL, human biosynthetic) EntuzityTM KwikPen®
Erbitux* (cetuximab)    
Evista® (raloxifene hydrochloride)   Health Care Professional Letter (May 2006)

Public Communication (May 2006)
Forteo® (teriparatide (rDNA origin) injection) Forteo® 2.4 mL Pen  
Glucagon (glucagon for injection, rDNA origin) Glucagon Handling Instructions - Video  
GlyxambiTM (empagliflozin and linagliptin tablets)    
Humalog® (insulin lispro for injection)
Humalog® 200 units/mL KwikPen® (insulin lispro for injection)
Humalog® Mix25® (25% insulin lispro injection, 75% insulin lispro protamine suspension)
Humalog® Mix50® (50% insulin lispro injection, insulin lispro protamine suspension)

Humalog® Vials

Humalog®  Cartridges

Humalog® 200 units/mL KwikPen®

Humalog®  Mix 25®  Cartridges

Humalog® Mix 50® Cartridges

 

 

 

Humalog® KwikPen®

Humalog® 200 units/mL KwikPen®

Humalog® Junior KwikPen®
   

Important safety information for HCPs and patients: Humalog® 200 units/mL KwikPen® (September 2015)
Humatrope® (somatropin for injection)

HumatroPen®6 mg

HumatroPen®12 mg

HumatroPen®24 mg

Hidden Needle Cover User Manual

Humatrope Handling Instructions - Video

 
Humulin® (insulin, human biosynthetic)
Humulin® N (insulin isophane (rDNA origin)) NPH
Humulin® R (insulin injection (rDNA origin)) Regular
Humulin® 30/70 (30% insulin injection, 70% insulin isophane (rDNA origin))
Humulin® N Cartridges and KwikPenTM
 
Humulin® N Vials

Humulin® R Cartridges and KwikPenTM

Humulin® R Vials

Humulin® 30/70 Cartridges

Humulin® 30/70 Vials
Humulin® N and Humulin® R KwikPenTM  
JardianceTM (empagliflozin tablets)   Important Safety Information for HCPs and patients: Jardiance™ (May 2016)
Jentadueto® (linagliptin/metformin HCl tablets)    
LartruvoTM (olaratumab)
Prozac® (fluoxetine hydrochloride)   Health Care Professional Letter (May 2004)
Reopro® (abciximab) Please see Health Canada’s Drug Product Database website for the current ReoPro® product monograph.  ReoPro® is owned and distributed by Janssen Inc.      
Strattera® (atomoxetine)   Health Care Professional Letter (Oct 2011)

Health Care Professional Letter (May 2006)

Health Care Professional Letter (Sept 2005)

Health Care Professional Letter (Feb 2005)

Public Communication  (Oct 2011)

Public Communication (May 2006)

Public Communication (Sept 2005)

Public Communication  (Feb 2005)
SynjardyTM (empagliflozin and metformin hydrochloride tablets)    
TaltzTM (ixekizumab)

TaltzTM Single-Use Prefilled Autoinjector

TaltzTM Single-Use Prefilled Syringe

 
Trajenta® (linagliptin)    
TrulicityTM (dulaglutide)

TrulicityTM Single-Use Pen, 0.75 mg/0.5 mL

TrulicityTM Single-Use Pen, 1.5 mg/0.5 mL

 

Zyprexa® (olanzapine)
Zyprexa® Zydis®*
Zyprexa® IntraMuscular (olanzapine tartrate for injection)
  Health Care Professional Letter  (Mar 2004)

Public Communication  (Mar 2004)



 

User Manuals for Re-useable Devices to be used with Humalog® and Humulin® family of products
HumaPen® Luxura®
HumaPen® Luxura® HD

HumaPen® Memoir®**
HumaPen® Memoir® Quick Guide

**No longer offered for sale.

HumaPen® SavvioTM

 

® Registered trademark owned by Eli Lilly and Company; used under license.
TM Trademark owned by Eli Lilly and Company; used under license.

TM of ImClone LLC

GlyxambiTM is a trademark used under license by Boehringer Ingelheim (Canada) Ltd. It’s co-promoted with Eli Lilly Canada Inc.

JardianceTM is a trademark used under license by Boehringer Ingelheim (Canada) Ltd. It’s co-promoted with Eli Lilly Canada Inc.

Jentadueto® is a registered trademark used under license by Boehringer Ingelheim (Canada) Ltd. It’s co-promoted with Eli Lilly Canada Inc.

SynjardyTM is a trademark used under license by Boehringer Ingelheim (Canada) Ltd. It’s co-promoted with Eli Lilly Canada Inc.

Trajenta® is a registered trademark used under license by Boehringer Ingelheim (Canada) Ltd.  It’s co-promoted with Eli Lilly Canada Inc.

®*Zydis is a trademark owned by R.P. Scherer Technologies, Inc., a Catalent Pharma Solutions Company. 


 

Lilly Canada is committed to diverting expired and/or unused health products from landfills and sewers, and ensuring their safe and effective collection and disposal. We are a member of the Health Products Stewardship Association.
Link to Health Products Stewardship Association web site
Don’t throw them out, visit www.medicationsreturn.ca

 

Link to Contact Us page
CONTACT US
Contact Us